JPWO2021157684A1 - - Google Patents
Info
- Publication number
- JPWO2021157684A1 JPWO2021157684A1 JP2021575876A JP2021575876A JPWO2021157684A1 JP WO2021157684 A1 JPWO2021157684 A1 JP WO2021157684A1 JP 2021575876 A JP2021575876 A JP 2021575876A JP 2021575876 A JP2021575876 A JP 2021575876A JP WO2021157684 A1 JPWO2021157684 A1 JP WO2021157684A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
- A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024001990A JP7681737B2 (ja) | 2020-02-06 | 2024-01-10 | Ｂｒｄ４蛋白質分解誘導作用を有するスルホンアミドあるいはスルフィンアミド化合物及びその医薬としての用途 |
| JP2025079628A JP2025122015A (ja) | 2020-02-06 | 2025-05-12 | Ｂｒｄ４蛋白質分解誘導作用を有するスルホンアミドあるいはスルフィンアミド化合物を製造するための化合物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020019227 | 2020-02-06 | ||
| JP2020019227 | 2020-02-06 | ||
| PCT/JP2021/004231 WO2021157684A1 (ja) | 2020-02-06 | 2021-02-05 | Ｂｒｄ４蛋白質分解誘導作用を有するスルホンアミドあるいはスルフィンアミド化合物及びその医薬としての用途 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024001990A Division JP7681737B2 (ja) | 2020-02-06 | 2024-01-10 | Ｂｒｄ４蛋白質分解誘導作用を有するスルホンアミドあるいはスルフィンアミド化合物及びその医薬としての用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2021157684A1 true JPWO2021157684A1 (https=) | 2021-08-12 |
| JP7419406B2 JP7419406B2 (ja) | 2024-01-22 |
Family
ID=77199607
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021575876A Active JP7419406B2 (ja) | 2020-02-06 | 2021-02-05 | Ｂｒｄ４蛋白質分解誘導作用を有するスルホンアミドあるいはスルフィンアミド化合物及びその医薬としての用途 |
| JP2024001990A Active JP7681737B2 (ja) | 2020-02-06 | 2024-01-10 | Ｂｒｄ４蛋白質分解誘導作用を有するスルホンアミドあるいはスルフィンアミド化合物及びその医薬としての用途 |
| JP2025079628A Pending JP2025122015A (ja) | 2020-02-06 | 2025-05-12 | Ｂｒｄ４蛋白質分解誘導作用を有するスルホンアミドあるいはスルフィンアミド化合物を製造するための化合物 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024001990A Active JP7681737B2 (ja) | 2020-02-06 | 2024-01-10 | Ｂｒｄ４蛋白質分解誘導作用を有するスルホンアミドあるいはスルフィンアミド化合物及びその医薬としての用途 |
| JP2025079628A Pending JP2025122015A (ja) | 2020-02-06 | 2025-05-12 | Ｂｒｄ４蛋白質分解誘導作用を有するスルホンアミドあるいはスルフィンアミド化合物を製造するための化合物 |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US12102641B2 (https=) |
| EP (1) | EP4105220A4 (https=) |
| JP (3) | JP7419406B2 (https=) |
| KR (1) | KR20220139912A (https=) |
| CN (1) | CN115087658B (https=) |
| AR (1) | AR121275A1 (https=) |
| AU (1) | AU2021215623A1 (https=) |
| BR (1) | BR112022014889A2 (https=) |
| CA (1) | CA3168824C (https=) |
| IL (1) | IL295041A (https=) |
| MX (1) | MX2022009700A (https=) |
| TW (1) | TWI887352B (https=) |
| WO (1) | WO2021157684A1 (https=) |
| ZA (1) | ZA202209896B (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7419406B2 (ja) | 2020-02-06 | 2024-01-22 | 田辺三菱製薬株式会社 | Ｂｒｄ４蛋白質分解誘導作用を有するスルホンアミドあるいはスルフィンアミド化合物及びその医薬としての用途 |
| JP2022123408A (ja) * | 2021-02-12 | 2022-08-24 | 株式会社三洋物産 | 遊技機 |
| JP2022123894A (ja) * | 2021-02-12 | 2022-08-25 | 株式会社三洋物産 | 遊技機 |
| JP2022123407A (ja) * | 2021-02-12 | 2022-08-24 | 株式会社三洋物産 | 遊技機 |
| JP2022123893A (ja) * | 2021-02-12 | 2022-08-25 | 株式会社三洋物産 | 遊技機 |
| JP7852736B2 (ja) * | 2022-10-28 | 2026-04-28 | 株式会社村田製作所 | 電子部品および電子部品の実装構造 |
| WO2024251876A1 (en) * | 2023-06-07 | 2024-12-12 | KRæFTENS BEKæMPELSE | PROTACs AND HyT-PD MOLECULES FOR TARGETED PROTEIN DEGRADATION OF DCAF15 AND THEIR USE IN THE TREATMENT OF AMYLOIDOSIS |
| CN118359621B (zh) * | 2024-04-16 | 2025-05-16 | 上海陶术生物科技股份有限公司 | 加利司伟及加利司伟中间体的制备方法和相应的加利司伟中间体 |
| CN120865239B (zh) * | 2025-09-25 | 2025-12-12 | 深圳大学 | 基于苯并咪唑融合共价弹头的降解剂及其制备方法与应用 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019189778A1 (ja) * | 2018-03-30 | 2019-10-03 | 協和発酵キリン株式会社 | 抗がん活性を有する化合物 |
| WO2020009176A1 (ja) * | 2018-07-04 | 2020-01-09 | 田辺三菱製薬株式会社 | Ｂｅｔ蛋白質分解誘導作用を有するアミド化合物及びその医薬としての用途 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4959361A (en) | 1987-12-18 | 1990-09-25 | Hoffmann-La Roche Inc. | Triazolo(4,3-A)(1,4)benzodiazepines and thieno (3,2-F)(1,2,4)triazolo(4,3-A)(1,4)diazepine compounds which have useful activity as platelet activating factor (PAF) antagonists |
| EP0638560A4 (en) | 1991-10-11 | 1995-03-29 | Yoshitomi Pharmaceutical | MEDICINE FOR OSTEOPOROSIS AND DIAZEPINE COMPOUND *. |
| WO1994006802A1 (fr) * | 1992-09-18 | 1994-03-31 | Yoshitomi Pharmaceutical Industries, Ltd. | Compose de thienodiazepine et son utilisation medicinale |
| JP2801500B2 (ja) | 1993-07-02 | 1998-09-21 | 株式会社トクヤマ | Ｎ−アルコキシカルボニルアミノ酸の製造方法 |
| CN1109037C (zh) | 1996-09-13 | 2003-05-21 | 三菱制药株式会社 | 噻吩并－三唑并二氮杂䓬化合物及其医药用途 |
| WO2006129623A1 (ja) | 2005-05-30 | 2006-12-07 | Mitsubishi Tanabe Pharma Corporation | チエノトリアゾロジアゼピン化合物及びその医薬としての用途 |
| AR084070A1 (es) | 2010-12-02 | 2013-04-17 | Constellation Pharmaceuticals Inc | Inhibidores del bromodominio y usos de los mismos |
| WO2017197056A1 (en) * | 2016-05-10 | 2017-11-16 | C4 Therapeutics, Inc. | Bromodomain targeting degronimers for target protein degradation |
| CN108727380A (zh) * | 2017-04-13 | 2018-11-02 | 中国科学院上海药物研究所 | 一种brd4抑制剂及其制备和应用 |
| CN109503618A (zh) * | 2017-09-14 | 2019-03-22 | 成都海创药业有限公司 | 一种brd4抑制剂 |
| EP3723757A4 (en) | 2017-12-14 | 2021-08-18 | Dana-Farber Cancer Institute, Inc. | SMALL MOLECULE TYPE DEGRADATION AGENTS RECRUITING DCAF15 |
| JP7140273B2 (ja) | 2019-04-09 | 2022-09-21 | 株式会社村田製作所 | 電池 |
| JP7419406B2 (ja) * | 2020-02-06 | 2024-01-22 | 田辺三菱製薬株式会社 | Ｂｒｄ４蛋白質分解誘導作用を有するスルホンアミドあるいはスルフィンアミド化合物及びその医薬としての用途 |
-
2021
- 2021-02-05 JP JP2021575876A patent/JP7419406B2/ja active Active
- 2021-02-05 MX MX2022009700A patent/MX2022009700A/es unknown
- 2021-02-05 CN CN202180012524.0A patent/CN115087658B/zh active Active
- 2021-02-05 TW TW110104483A patent/TWI887352B/zh active
- 2021-02-05 IL IL295041A patent/IL295041A/en unknown
- 2021-02-05 WO PCT/JP2021/004231 patent/WO2021157684A1/ja not_active Ceased
- 2021-02-05 AR ARP210100302A patent/AR121275A1/es unknown
- 2021-02-05 US US17/796,258 patent/US12102641B2/en active Active
- 2021-02-05 EP EP21750647.6A patent/EP4105220A4/en active Pending
- 2021-02-05 KR KR1020227030071A patent/KR20220139912A/ko active Pending
- 2021-02-05 BR BR112022014889A patent/BR112022014889A2/pt unknown
- 2021-02-05 AU AU2021215623A patent/AU2021215623A1/en active Pending
- 2021-02-05 CA CA3168824A patent/CA3168824C/en active Active
-
2022
- 2022-09-05 ZA ZA2022/09896A patent/ZA202209896B/en unknown
-
2023
- 2023-07-20 US US18/355,554 patent/US11890288B2/en active Active
-
2024
- 2024-01-10 JP JP2024001990A patent/JP7681737B2/ja active Active
- 2024-08-06 US US18/795,713 patent/US20240390387A1/en active Pending
-
2025
- 2025-05-12 JP JP2025079628A patent/JP2025122015A/ja active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019189778A1 (ja) * | 2018-03-30 | 2019-10-03 | 協和発酵キリン株式会社 | 抗がん活性を有する化合物 |
| WO2020009176A1 (ja) * | 2018-07-04 | 2020-01-09 | 田辺三菱製薬株式会社 | Ｂｅｔ蛋白質分解誘導作用を有するアミド化合物及びその医薬としての用途 |
Also Published As
| Publication number | Publication date |
|---|---|
| KR20220139912A (ko) | 2022-10-17 |
| US20230146717A1 (en) | 2023-05-11 |
| TWI887352B (zh) | 2025-06-21 |
| ZA202209896B (en) | 2025-12-17 |
| MX2022009700A (es) | 2022-09-07 |
| US12102641B2 (en) | 2024-10-01 |
| WO2021157684A1 (ja) | 2021-08-12 |
| EP4105220A4 (en) | 2024-02-21 |
| IL295041A (en) | 2022-09-01 |
| AU2021215623A1 (en) | 2022-08-25 |
| CA3168824C (en) | 2024-10-22 |
| TW202140498A (zh) | 2021-11-01 |
| US20230364105A1 (en) | 2023-11-16 |
| AR121275A1 (es) | 2022-05-04 |
| CN115087658B (zh) | 2025-02-28 |
| JP2024041888A (ja) | 2024-03-27 |
| JP7419406B2 (ja) | 2024-01-22 |
| CA3168824A1 (en) | 2021-08-12 |
| EP4105220A1 (en) | 2022-12-21 |
| JP2025122015A (ja) | 2025-08-20 |
| CN115087658A (zh) | 2022-09-20 |
| US11890288B2 (en) | 2024-02-06 |
| JP7681737B2 (ja) | 2025-05-22 |
| BR112022014889A2 (pt) | 2022-09-20 |
| US20240390387A1 (en) | 2024-11-28 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220802 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230912 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20231006 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20231212 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240110 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7419406 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R157 | Certificate of patent or utility model (correction) |
Free format text: JAPANESE INTERMEDIATE CODE: R157 |
|
| RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: R3D02 |